Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parks

Showing results (161-170 of 6,494) with videos related to

Pageof 650
Sort By:
Nursing Reports (Pavia, Italy)|September 26, 2025
Development and Psychometric Evaluation of a Theory-Based Preceptorship Survey for Nurse PractitionersLeonie DeClerk, Brian Parks
The Journal of Infectious Diseases|April 1, 1987
Simultaneous infections with human T cell leukemia virus type I and the human immunodeficiency virusS B Kanner, E S Parks, G B Scott, et al.
Cardiovascular Research|June 1, 1984
Regional distribution of brain and myocardial perfusion in swine while awake and during 1.0 and 1.5 MAC isoflurane anaesthesia produced without or with 50% nitrous oxideM Manohar, C Parks
Bioanalysis|September 24, 2013
Bioanalysis annual round-up: the bioanalysis editorial team is delighted to welcome you to this mid-year round-upAlice O'Hare, Lisa Parks
Entropy (Basel, Switzerland)|December 3, 2020
Capacity and Entropy of a Retro-Causal Channel Observed in a Twin Mach-Zehnder Interferometer During Measurements of Pre- and Post-Selected Quantum SystemsAllen Parks, Scott Spence
Review of European, Comparative & International Environmental Law|December 27, 2016
The Need for an Interdisciplinary Approach to Norm Diffusion: The Case of Fair and Equitable Benefit-sharingLouisa Parks, Elisa Morgera
Analytical Biochemistry|May 27, 2018
Fluorescence alteration of MPA capped CdSe quantum dots by spontaneous biomarker protein adsorptionAmber Rowley, Tegan Parks, Kaden Parks, et al.
Current Gene Therapy|July 12, 2002
Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapyAndrea Amalfitano, Robin J Parks
Pharmaceutical Research|June 28, 2000
What is the true solubility advantage for amorphous pharmaceuticals?B C Hancock, M Parks
Journal of Virology|April 5, 2019
Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and ReplicationBratati Saha, Robin J Parks
Pageof 650

Showing results (161-170 of 6,494) with videos related to

Sort By:
Pageof 650
Nursing Reports (Pavia, Italy)|September 26, 2025
Development and Psychometric Evaluation of a Theory-Based Preceptorship Survey for Nurse PractitionersLeonie DeClerk, Brian Parks
The Journal of Infectious Diseases|April 1, 1987
Simultaneous infections with human T cell leukemia virus type I and the human immunodeficiency virusS B Kanner, E S Parks, G B Scott, et al.
Cardiovascular Research|June 1, 1984
Regional distribution of brain and myocardial perfusion in swine while awake and during 1.0 and 1.5 MAC isoflurane anaesthesia produced without or with 50% nitrous oxideM Manohar, C Parks
Bioanalysis|September 24, 2013
Bioanalysis annual round-up: the bioanalysis editorial team is delighted to welcome you to this mid-year round-upAlice O'Hare, Lisa Parks
Entropy (Basel, Switzerland)|December 3, 2020
Capacity and Entropy of a Retro-Causal Channel Observed in a Twin Mach-Zehnder Interferometer During Measurements of Pre- and Post-Selected Quantum SystemsAllen Parks, Scott Spence
Review of European, Comparative & International Environmental Law|December 27, 2016
The Need for an Interdisciplinary Approach to Norm Diffusion: The Case of Fair and Equitable Benefit-sharingLouisa Parks, Elisa Morgera
Analytical Biochemistry|May 27, 2018
Fluorescence alteration of MPA capped CdSe quantum dots by spontaneous biomarker protein adsorptionAmber Rowley, Tegan Parks, Kaden Parks, et al.
Current Gene Therapy|July 12, 2002
Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapyAndrea Amalfitano, Robin J Parks
Pharmaceutical Research|June 28, 2000
What is the true solubility advantage for amorphous pharmaceuticals?B C Hancock, M Parks
Journal of Virology|April 5, 2019
Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and ReplicationBratati Saha, Robin J Parks
Pageof 650